Cargando…
Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma
Gastric cancer is a common malignancy and remains one of the leading causes of cancer-related deaths, though its incidence is in decline in most developed countries. One of the major challenges of treating gastric cancer is tumor heterogeneity, which portends a high degree of prognostic variance and...
Autores principales: | Luo, Wenyi, Nagaria, Teddy S., Sun, Hongxia, Ma, Junsheng, Lombardo, Jamie L., Bassett, Roland, Cao, Austin C., Tan, Dongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863590/ https://www.ncbi.nlm.nih.gov/pubmed/35221802 http://dx.doi.org/10.3389/pore.2022.1610293 |
Ejemplares similares
-
Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma
por: Zhou, Zhiyi, et al.
Publicado: (2022) -
Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer
por: Qadir, Jasiya, et al.
Publicado: (2021) -
Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021) -
IL-33 Participates in the Development of Esophageal Adenocarcinoma
por: Liu, Jia, et al.
Publicado: (2022) -
Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients
por: Liang, Yiqian, et al.
Publicado: (2022)